In HCC driven by obesity and nonalcoholic steatohepatitis, the downregulation of CPT2 leads to the accumulation of acylcarnitines, among which C18:1-carnitine enhances spheroid formation by HCC cells through STAT3 activation, indicating that the accumulation of acylcarnitine can promote the development of liver cancer [212]
However, maintaining a healthy lifestyle is essential to prevent new fat deposits from forming in the treated areas
Carnitine deficiency occurs in aberrations of carnitine regulation in disorders such as diabetes, sepsis, cardiomyopathy, malnutrition, cirrhosis, endocrine disorders and with aging
Mahmood S, Ishtiaq S, Yasin G, Irshad A (2016) Dose dependent rhizospheric Ni toxicity evaluation: membrane stability and antioxidant potential of Vigna species
What clinical evidence supports tirzepatide for weight loss